These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17537555)

  • 41. Successful application of monolithic innovative technology using a carbonyldiimidazole disk to purify supercoiled plasmid DNA suitable for pharmaceutical applications.
    Sousa A; Tomaz CT; Sousa F; Queiroz JA
    J Chromatogr A; 2011 Nov; 1218(46):8333-43. PubMed ID: 21995857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fractional precipitation of plasmid DNA from lysate by CTAB.
    Lander RJ; Winters MA; Meacle FJ; Buckland BC; Lee AL
    Biotechnol Bioeng; 2002 Sep; 79(7):776-84. PubMed ID: 12209800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A modified alkaline lysis method for the preparation of highly purified plasmid DNA from Escherichia coli.
    Feliciello I; Chinali G
    Anal Biochem; 1993 Aug; 212(2):394-401. PubMed ID: 8214582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Large-scale capture and partial purification of plasmid DNA using anion-exchange membrane capsules.
    Zhang S; Krivosheyeva A; Nochumson S
    Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):245-9. PubMed ID: 12656677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A continuous process to extract plasmid DNA based on alkaline lysis.
    Li X; Jin H; Wu Z; Rayner S; Wang B
    Nat Protoc; 2008; 3(2):176-80. PubMed ID: 18274518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purification of plasmid DNA using tangential flow filtration and tandem anion-exchange membrane chromatography.
    Guerrero-Germán P; Prazeres DM; Guzmán R; Montesinos-Cisneros RM; Tejeda-Mansir A
    Bioprocess Biosyst Eng; 2009 Aug; 32(5):615-23. PubMed ID: 19083017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasmid DNA for pharmaceutical applications.
    Schleef M; Schmidt T; Flaschel E
    Dev Biol (Basel); 2000; 104():25-31. PubMed ID: 11713820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient purification of plasmid DNA for gene transfer using triple-helix affinity chromatography.
    Wils P; Escriou V; Warnery A; Lacroix F; Lagneaux D; Ollivier M; Crouzet J; Mayaux JF; Scherman D
    Gene Ther; 1997 Apr; 4(4):323-30. PubMed ID: 9176518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pilot-scale production and quality control of multiepitope hepatitis B virus DNA vaccine].
    Guo Y; Hui CY
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):118-20. PubMed ID: 19218129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Production of plasmid DNA for pharmaceutical use.
    Voss C
    Biotechnol Annu Rev; 2007; 13():201-22. PubMed ID: 17875478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of a topologically aberrant plasmid population from pilot-scale production of clinical-grade DNA.
    Weigl D; Molloy MJ; Clayton TM; Griffith J; Smith CR; Steward T; Merrill BM; Deprince RB; Jone CS; Persmark M
    J Biotechnol; 2006 Jan; 121(1):1-12. PubMed ID: 16150507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Purification of supercoiled plasmid.
    Green AP
    Methods Mol Med; 2000; 29():1-9. PubMed ID: 21374304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The suitability of DEAE-Cl active groups on customized poly(GMA-co-EDMA) continuous stationary phase for fast enzyme-free isolation of plasmid DNA.
    Danquah MK; Forde GM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):38-46. PubMed ID: 17400523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purification of plasmid DNA using selective precipitation by compaction agents.
    Murphy JC; Wibbenmeyer JA; Fox GE; Willson RC
    Nat Biotechnol; 1999 Aug; 17(8):822-3. PubMed ID: 10429254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization of isopropanol and ammonium sulfate precipitation steps in the purification of plasmid DNA.
    Freitas SS; Santos JA; Prazeres DM
    Biotechnol Prog; 2006; 22(4):1179-86. PubMed ID: 16889396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris.
    Faber BW; Remarque EJ; Kocken CH; Cheront P; Cingolani D; Xhonneux F; Jurado M; Haumont M; Jepsen S; Leroy O; Thomas AW
    Vaccine; 2008 Nov; 26(48):6143-50. PubMed ID: 18804135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Automated alkaline lysis for industrial scale cGMP production of pharmaceutical grade plasmid-DNA.
    Urthaler J; Ascher C; Wöhrer H; Necina R
    J Biotechnol; 2007 Jan; 128(1):132-49. PubMed ID: 17129627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An automated process to extract plasmid DNA by alkaline lysis.
    Li X; Jin H; Wu Z; Rayner S; Yin J; Yu Y; Zhang W; He Z; Wang C; Wang B
    Appl Microbiol Biotechnol; 2007 Jul; 75(5):1217-23. PubMed ID: 17387470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines.
    Ongkudon CM; Ho J; Danquah MK
    Crit Rev Biotechnol; 2011 Mar; 31(1):32-52. PubMed ID: 20879832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gram-scale production of plasmid pUDK-HGF with current good manufacturing practices for gene therapy of critical limb ischemia.
    Hu C; Cheng X; Lu Y; Wu Z; Zhang Q
    Prep Biochem Biotechnol; 2016 Nov; 46(8):844-849. PubMed ID: 26853514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.